Table 2 Visual acuity distribution after single session of triple therapy for neovascular age-related macular degeneration
| LogMAR best-corrected visual acuity | 3 months (%) (n) | 6 months (%) (n) |
| Gaining vision | 52.7 (19/36) | 41.7 (15/36) |
| ⩾3 lines | 30.5 (11/36) | 27.8 (10/36) |
| <3 lines | 22.2 (8/36) | 13.8 (5/36) |
| Stable vision | 13.8 (5/36) | 19.4 (7/36) |
| Losing vision | ||
| <3 lines | 8.3 (3/36) | 13.9 (5/36) |
| ⩾3 to <6 lines | 13.9 (5/36) | 8.3 (3/36) |
| ⩾6 lines | 11.1 (4/36) | 16.7 (6/36) |
